About 2,190 results
Open links in new tab
Biotech and Pharma Industry News | BioPharma Dive
Two decades and $200 billion: AbbVie’s Humira monopoly nears …
Gilead wins approval of CAR-T therapy in adult leukemia
Biotech M&A has plateaued. Track the deals that are happening …
Meso Scale Discovery (MSD): An immunoassay platform with …
A three-decade monopoly: how Amgen built a patent thicket …
Biotech IPOs are the industry’s lifeblood. Track how they’re …
A decade later, biotech’s CRISPR revolution is still going strong
Biotech News - BioPharma Dive
Lilly wins FDA approval for new kind of diabetes drug